Varex Imaging Corporation (VREX) specializes in the development and production of X-ray imaging components. Its operations are divided into two primary divisions: ...
Plutux is not an investment adviser. Market data and AI-generated analysis are for information and education only, not investment advice. Disclaimer
Est. EPS $0.88 · Revenue $865.95M · 3 analysts
Est. EPS $0.17 · Revenue $216.40M · 2 analysts
Est. EPS $0.23 · Revenue $222.15M · 1 analysts
Est. EPS $0.23 · Revenue $223.40M · 1 analysts
| Metric | Latest | YoYYoY means Year-over-Year. It compares the latest annual value with the previous annual value to show long-term trend strength. | QoQQoQ means Quarter-over-Quarter. It compares the latest quarter with the immediately previous quarter to show short-term momentum changes. |
|---|---|---|---|
| RevenueThe total money that came through the front door from selling things, before paying a single bill. Think of it as the grand total of every credit card swipe from customers. (YoY compares this year to last year's performance, while QoQ compares the current three months to the previous three). | $844.6M | +4.1% | -2.5% |
| Net IncomeThe absolute bottom line. If the company paid every single supplier, employee, banker, and tax collector, this is the actual money left in their pocket at the end of the day. | $-70.3M | -47.4% | +293.8% |
| Gross MarginThe basic markup. If they sell a $100 pair of sneakers, this percentage tells you how much of that price tag is profit right after paying for the rubber and shoelaces, but before paying for things like store rent or TV commercials. | +34.4% | +8.6% | +8.4% |
| Operating MarginThe 'day job' efficiency score. Out of every dollar a customer spends, this shows how many cents the company keeps after making the product AND paying for all the everyday corporate overhead (like salaries, marketing, and keeping the lights on). | -3.3% | -183.2% | +62.5% |
| Net MarginThe final take-home percentage. When you strip away every conceivable cost, tax, and interest payment, this is the exact number of cents the company truly gets to keep from every dollar in sales. | -8.3% | -41.5% | +298.9% |
| Free Cash FlowThe holy grail of corporate cash. It's the spendable, physical money left over after the business pays for its daily operations AND buys the big, expensive upgrades (like new factories or servers) it needs to survive. This is the 'free' money they can use to pay dividends or buy back stock. | $18.8M | -7.8% | +255.8% |
| FCF MarginThe ultimate cash conversion rate. It shows how good the company is at turning regular sales directly into cold, hard, spendable cash. A high percentage means the business is an absolute cash-printing machine. | +2.2% | -11.5% | +259.9% |
| Debt / EquityThe financial risk gauge. It compares how much of the company's empire was built using borrowed money (loans) versus the owners' own money (shareholders). A high number means they are heavily leveraged and playing a riskier game; a low number means they are playing it safe. | 85.0% | -3.3% | -6.4% |
| Current RatioThe 12-month survival check. It simply compares the cash they have right now (plus things they can quickly turn into cash) against the immediate bills they absolutely must pay this year. A score above 1 means they have enough in the wallet to cover the upcoming bills without panicking. | 3.43x | +3.3% | +5.5% |
| Total AssetsThe absolute size of the company's empire. It bundles together absolutely everything of value they own—from the cash in the register and the inventory in the warehouse, to the software patents in the vault and the factories on the ground. | $1.1B | -9.0% | +1.0% |
| Metric | Annual (A vs E) | Annual Surprise | Quarter (A vs E) | Quarter Surprise |
|---|---|---|---|---|
| EPS Surprise | -1.70 vs 0.68 | -349.1% | 0.37 vs 0.21 | +76.1% |
| Revenue Surprise | $844.6M vs $835.0M | +1.2% | $210.5M vs $215.5M | -2.3% |
| Date | Executive | Title | Security | Side | Shares | Price |
|---|---|---|---|---|---|---|
| Aug 14, 2026 | Aranki Karen L | officer: Chief Human Resources Officer | Common Stock | A | 3,974 | — |
| Aug 14, 2026 | Aranki Karen L | officer: Chief Human Resources Officer | Common Stock | D | 1,145 | $18.49 |
| Aug 14, 2026 | Aranki Karen L | officer: Chief Human Resources Officer | Restricted Stock Units | D | 3,974 | — |
| Mar 20, 2026 | Kunkel Jay K. | director | Common Stock | D | 4,510 | $11.14 |
| Feb 13, 2026 | Merkley Jesse Don | officer: SVP and GM, Industrial | Common Stock | — | 0 | — |
Operator: Greetings, and welcome to Varex's Q2 Fiscal Year '26 Earnings Call. [Operator Instructions] It is now my pleasure to introduce Chris Belfiore, Director of Investor Relations. Please go ahead. Christopher Belfiore: Good afternoon, and welcome to Varex Imaging's Earnings Conference Call for the Second Quarter fiscal year 2026. With me today are Sunny Sanyal, our President and CEO; and Sam Maheshwari, our CFO. Please note that the live webcast of this conference call includes a supplemental slide presentation that can be accessed at Varex's website at vareximaging.com. The webcast and supplemental slide presentation will be archived on Varex's website. To simplify our discussion, unless otherwise stated, all references to the quarter are for the second quarter of fiscal year 2026 and to the year are for the fiscal year 2026. In addition, unless otherwise stated, quarterly comparisons are made year-over-year from the second quarter of fiscal year 2026 to the second quarter of fiscal year 2025. Finally, all references to the year are to the fiscal year and not the calendar year, unless otherwise stated. Please be advised that during this call, we will be making forward-looking statements, which are predictions or projections about future events. These statements are based on current information, expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated. Risks relating to our business are described in our quarterly earnings release and our filings with the SEC. Additional information concerning factors that could cause actual results to materially differ from those anticipated is contained in our SEC filings, including Item 1A, Risk Factors of our quarterly reports on Form 10-Q and our annual report on Form 10-K. The information in this discussion speaks as of today's date, and we assume no obligation to update or revise the forward-looking statements in this discussion. On today's call, we will discuss certain non-GAAP financial measures. Our non-GAAP measures are not presented in accordance with, nor are they a substitute for GAAP financial measures. We provided a reconciliation of each non-GAAP financial measure to the most directly comparable GAAP financial measure in our earnings press release, which is posted on our website. I will now turn the call over to Sunny. Sunny Sanyal: Thank you, Chris. Good afternoon, everyone, and thank you for joining us for our second quarter earnings call. I'm pleased to say that we delivered a solid second quarter in both Medical and Industrial while strengthening our capital structure and continuing to shift our business towards advanced imaging technologies and higher-growth industrial applications. Revenue for the quarter came in within the guidance range at $216 million. Non-GAAP gross margin was 34% and non-GAAP EPS was $0.21. I'd also like to highlight that during the quarter, we completed our debt …
| Name | Title | Compensation | Gender | Year Born | Status |
|---|---|---|---|---|---|
Sunny S. Sanyal | President, Chief Executive Officer & Director | USD 1,971,710 | Male | 1964 | Active |
Shubham Maheshwari | Chief Financial Officer & Principal Accounting Officer | USD 1,078,606 | Male | 1971 | Active |
Andrew J. Hartmann | Senior Vice President & GM of X-ray Detectors | USD 812,150 | Male | 1963 | Active |
Kimberley E. Honeysett | Advisor | USD 786,361 | Female | 1970 | Active |
Mark S. Jonaitis | Senior Vice President & GM of X-Ray Sources | USD 740,235 | Male | 1962 | Active |
Karen Aranki | Chief Human Resources Officer | USD 450,175 | Female | 1975 | Active |
Jesse Don Merkley | Senior Vice President & GM of Industrial Imaging | — | — | — | Active |
Christopher John Belfiore | Director of Investor Relations | — | Male | — | Active |
Matthew Martinez | Chief Legal Officer & Corporate Secretary | — | Male | 1982 | Active |
Victor Garcia | Senior Vice President of Regulatory & Quality Compliance | — | Male | — | Active |
Shaohua Liang | VP & MD of China | — | Male | — | Active |
Wouter Vlaanderen | Vice President of Global Marketing | — | Male | — | Active |
BlackRock Inc. bought a new position in Varex Imaging (NASDAQ: VREX) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 3,894,891 shares of the company's stock, valued at approximately $40,624,000. BlackRock Inc. owned about 9.25% of Varex Imaging at
BALA CYNWYD, Pa., Aug. 28, 2026 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
$HAREHOLDER ALERT: The M&A Class Action Firm Announce the Investigation of the Merger - CHMI, VREX, HHS and ARX PR Newswire
Are SUNS, VREX, CHMI, FBRX Obtaining Fair Deals for their Shareholders? PR Newswire NEW YORK, Aug. 12, 2026
